NCT06420349 2025-12-22NXP800 for the Treatment of Patients With Advanced or Metastatic CholangiocarcinomaMayo ClinicPhase 1 Terminated7 enrolled
NCT06058663 2025-10-20Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic CholangiocarcinomaMayo ClinicPhase 1 Recruiting16 enrolled